Introduction Liver cirrhosis accounts for considerable morbidity and mortality worldwide and late presentation limits therapeutic options. We aimed to assess characteristics of patients with liver cir
Background and aims: Hepatic venous pressure gradient (HVPG) is a strong surrogate of severity and outcome but its relative prognostic value in metabolic dysfunction-associated steatotic liver disease
*Deaths and survivors at 90 days of follow-up, ignoring censored observations. †Observed mortality at 90-days estimated from Kaplan-Meier curve using all observations within each cell. In total, 3921
Correlations with pharmacokinetic parameters were performed in patients (n = 13) and controls (n = 5) while correlation with prognostic factors were only performed in patients (n = 13). Patients 3 and